Greenberg Traurig is a sponsor of the 22nd Annual Paragraph IV Disputes taking place at The Times Center in New York on April 21 - 22, 2026. This event brings together pharmaceutical patent practitioners to examine the evolving “patent endgame.” Attendees analyze the impact of key court decisions, legislative developments, regulatory actions, and industry trends shaping high-stakes pharmaceutical patent litigation and related business strategies.
The program features insights from members of the federal judiciary, the U.S. Patent and Trademark Office’s PTAB, the FTC, and the FDA, alongside leaders from both brand and generic drug companies.